Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27, 2024.
It is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss the de-escalation and escalation of surgery, radiotherapy, and adjuvant treatments. Stephen Johnston from the UK will focus on personalizing adjuvant endocrine therapy, exploring current perspectives and future directions. Following the talks, there will be a 10-minute discussion and Q&A session, allowing participants to engage with the speakers.
The event will conclude with closing remarks by Fiorita Poulakaki, summarizing the key takeaways.
